Pharmaceutical trends and the role of MES

Published: 26-Apr-2017
Media Manufacturing

With trends in the pharmaceutical industry continuously evolving, manufacturers are under increasing pressure to keep pace and adapt their operations to meet changing needs

You need to be a subscriber to read this article.
Click here to find out more.

In this article, Christian Fortunel, Vice President of LZ Lifescience, discusses today’s most significant market trends, including continuous manufacturing, the increased demand for individualised medicines, patient-centricity and globalisation, as well as FDA’s focus on quality, and addresses the advantages that manufacturing execution systems (MES) bring in meeting the complexities of these developments.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.
See more

You may also like

Media

ACG wins Red Dot Design Award for breakthrough Personalised Medicine Concept

Read more
ACG’s Personalised Medicine Concept (PMC) has earned the Red Dot Award for high design quality, recognising its pioneering approach to capsule-based personalised health solutions developed through the collaborative OneACG ecosystem

Trending Articles

  1. Lilly partners with NVIDIA to build pharma’s most powerful AI supercomputer for faster drug discovery Eli Lilly has joined forces with NVIDIA to create the world’s most powerful pharmaceutical supercomputer, designed to accelerate AI-driven medicine discovery and manufacturing — all while running entirely on renewable energy
  2. Enzene wins CPHI Manufacturing Excellence award The Enzene platform was one of four finalists selected by a panel of pharma industry experts.
  3. OPTIMA machinery USA Corporation marks 40 years of growth and innovation in the US OPTIMA machinery USA Corporation, a subsidiary of the German-based OPTIMA Packaging Group, is celebrating 40 years of successful operations in the United States
  4. Aseptic spray drying: Transforming biotherapeutics for a new era With interest in aseptic spray drying on the rise in the pharmaceutical industry, Dr Kevin Robinson spoke to GEA’s David Costes about how the company is combining process, engineering and technological expertise with market insights to provide a safe, reliable and high-performance technology for advanced biotherapeutic powder applications
  5. How to execute a successful remediation strategy NSF’s experts share guidance on building sustainable compliance and avoiding quick fixes

You may also like

Media

ACG wins Red Dot Design Award for breakthrough Personalised Medicine Concept

ACG’s Personalised Medicine Concept (PMC) has earned the Red Dot Award for high design quality, recognising its pioneering approach to capsule-based personalised health solutions developed through the collaborative OneACG ecosystem
Manufacturing

Domino launches Dx1060i 100W CO² laser coder for high-speed beverage production

Domino’s new high-power laser enables manufacturers to code larger, more complex designs clearly and quickly on plastics, glass, and other challenging beverage substrates
Manufacturing

Driving ADC innovation with complex chemistry solutions

Abzena’s tailored chemistry expertise enables scalable, high-quality bioconjugate development from discovery to GMP production
Manufacturing

Accelerating technology transfer in biopharmaceutical manufacturing

This article explores how structured, digitally enabled and integrated technology transfer frameworks are accelerating the commercialisation of complex biopharmaceutical modalities by enhancing precision, speed and regulatory readiness
Manufacturing

Eli Lilly to build a new $3bn facility to boost oral medicine manufacturing capacity in Europe

The Netherlands site will bring 500 manufacturing and 1500 construction jobs while further strengthening Lilly's global supply chain
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

What’s really driving commercial technology transfer delays and how to prevent them

Judith Zamparo, Technical Manager and Anant Patel, Technical Process Lead at Bora Pharmaceuticals, examine the key causes of commercial technology transfer delays in the pharmaceutical industry and offer practical strategies to overcome them
Manufacturing

Buchiglas offers proven reactor solutions for solid phase peptide synthesis (SPPS)

Scalable systems for research, development, and GMP production
Subscribe now